Skip to content

InflaRx N.V.

IFRX· NasdaqCore metricsCIK 1708688

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · +5.53%
Market cap
$89.64M
72.29M shares
Filings
291
€29.33K
FY 2025−82.3% FY25 yoy
-€45.63M
FY 2025N/M FY25 yoy
-€44.91M
FY 2023N/M FY23 yoy
-€21.71M
Q2 2023derived
—
-€0.68
FY 2025N/M FY25 yoy
€16.02M
FY 2025−12.8% FY25 yoy
$89.64M
—
—
—
—
—

Price

$1.2424.85%$0.41past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

€29.33KFY 2025
€165.79K0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31€29,331reported
FY 20242024-12-31€165,789reported
FY 20232023-12-31€63,089reported

Segments

Geography
Long-lived assets by Geography, FY2019 to FY2022FY2019Germany · FY2019 · €2.22MUnited States · FY2019 · €374.00KFY2020Germany · FY2020 · €1.71MUnited States · FY2020 · €219.00KFY2021Germany · FY2021 · €1.71MUnited States · FY2021 · €219.00KFY2022Germany · FY2022 · €29.26MUnited States · FY2022 · €200.00K
LineFY2022ShareChange
Germany€29.26M587%+1,609.2%
United States€200.00K4.0%−8.7%
Germany———
United States———
Total€4.99M

From the 20-F filed Mar 24, 2022IFRX

Pharmaceutical preparations

InflaRx N.V. is the 297th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

InflaRx N.V. · CIK 1708688 · Engraved from SEC EDGAR